Linezolid Dosing for a 43 kg Boy
For a 43 kg boy, administer linezolid 430 mg (10 mg/kg/dose) PO/IV every 8 hours, not to exceed 600 mg per dose. This dosing is based on established IDSA guidelines for pediatric patients under 12 years of age 1.
Dosing Algorithm
The appropriate linezolid dose depends on the patient's age and weight:
If the boy is under 12 years old: Use 10 mg/kg/dose every 8 hours (430 mg per dose for 43 kg), with a maximum of 600 mg per dose 1
- Total daily dose: 1,290 mg/day (30 mg/kg/day)
If the boy is 12 years or older: Use the adult dose of 600 mg every 12 hours 1
- Total daily dose: 1,200 mg/day
Rationale and Evidence
The IDSA guidelines from 2011 provide clear, evidence-based dosing recommendations for linezolid across all pediatric age groups 1. These guidelines are consistent across multiple infection types including complicated skin and soft tissue infections, pneumonia, bone and joint infections, and CNS infections.
Pharmacokinetic justification: Pediatric patients aged 3 months to 11 years demonstrate more rapid linezolid clearance compared to adolescents and adults 2. The every-8-hour dosing regimen in younger children achieves similar daily AUC values to the every-12-hour regimen used in adolescents and adults, ensuring therapeutic efficacy 2.
The FDA label confirms that clearance is most rapid in children aged >1 week to 11 years, necessitating the three-times-daily dosing to maintain adequate drug exposure 2. By adolescence (≥12 years), clearance values approach adult levels, allowing transition to twice-daily dosing 2.
Critical Monitoring Considerations
Hematologic toxicity is the primary concern with linezolid therapy:
- Monitor complete blood counts weekly, especially if treatment exceeds 14 days 3
- Risk of hematologic toxicity increases significantly with:
Therapeutic drug monitoring should be considered for:
- Treatment courses exceeding 14 days
- Patients with renal impairment (though dose adjustment is not routinely required) 2
- Patients experiencing hematologic toxicity
Common Pitfalls to Avoid
Do not use adult dosing (600 mg q12h) in children under 12 years: This results in subtherapeutic exposure due to faster clearance in younger patients 2
Do not exceed 600 mg per dose: Even though the calculated dose for a 43 kg patient would be 430 mg, the maximum single dose is capped at 600 mg 1
Do not use twice-daily dosing in younger children: Research shows twice-daily dosing results in higher peak concentrations and increased anemia risk compared to three-times-daily regimens at equivalent total daily doses 3
Do not neglect renal function assessment: While dose adjustment is not required for renal impairment, metabolites accumulate and may contribute to toxicity 2